Bayesian Capital Management’s iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-7,700
Closed -$361K 874
2018
Q4
$361K Buy
+7,700
New +$285K 0.07% 362
2017
Q2
Sell
-2,750
Closed -$174K 691
2017
Q1
$174K Buy
+2,750
New +$204K 0.08% 361
2016
Q3
Sell
-938
Closed -$207K 627
2016
Q2
$207K Buy
+938
New +$234K 0.12% 330

Bayesian Capital Management's VXX Position: Q1 2019 in Review

Bayesian Capital Management sold out of iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 (VXX) in Q1 2019, closing a stake of 7,700 shares — an estimated $361K sold.

Bayesian Capital Management first reported a position in VXX in Q2 2016 and held it in 3 quarters. The position peaked at $361K in Q4 2018. 0 funds tracked by Wall St. Rank hold VXX as of Q1 2019.

  • Bayesian Capital Management reported no remaining iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 position as of Q1 2019 after selling out during the quarter.
  • Bayesian Capital Management sold 7,700 iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 shares in Q1 2019, an estimated $361K.
  • Bayesian Capital Management first reported a position in iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q2 2016 and held it in 3 quarters.
  • Bayesian Capital Management's iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 position peaked at $361K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 as of Q1 2019.

Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.